Pfizer is currently trading at Rs. 2796.70, up by 115.20 points or 4.30% from its previous closing of Rs. 2681.50 on the BSE.
The scrip opened at Rs. 2799.00 and has touched a high and low of Rs. 2844.00 and Rs. 2781.10 respectively. So far 7419 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 3840.00 on 29-Aug-2018 and a 52 week low of Rs. 2050.60 on 23-Mar-2018.
Last one week high and low of the scrip stood at Rs. 2844.00 and Rs. 2650.00 respectively. The current market cap of the company is Rs. 12800.22 crore.
The promoters holding in the company stood at 63.92%, while Institutions and Non-Institutions held 15.98% and 20.10% respectively.
The company has reported a rise of 51.24% in its net profit at Rs 131.94 crore for third quarter ended December 31, 2018 as compared to Rs 87.24 crore for the same quarter in the previous year. Total income of the company increased by 18.32% at Rs 578.14 crore for Q3FY19 as compared Rs 488.62 crore for the corresponding quarter previous year.
Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.
